908 Devices Inc (MASS) Stock Price, Quote & News

Company Profile

908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that ra...

Industry: Medical Devices

Sector: Healthcare

Phone: 857-254-1500

Website: 908devices.com

Address:

44 3rd Avenue, Burlington, United States

LandonCapital May. 6 at 4:59 PM

$MASS https://landoncapital.net/908-devices-acquires-nirlab-for-15-million-in-narcotics-detection-deal/

0 · Reply

xbizo May. 6 at 2:20 PM

$MASS Guidance raise VipIR rollout confirmation Smiths Spring Award coming Neurolab acquisition 30% recurring revenue milestone hit Near-zero cash burn

1 · Reply

xbizo May. 6 at 2:09 PM

$MASS run to $10 and back off from there? Thoughts?

0 · Reply

DARKP00L May. 6 at 12:47 PM

$MASS 07:38 on May. 06 2026 908 Devices Raises FY2026 Sales Guidance from $64.500M-$67.500M to $67.000M-$70.000M vs $65.808M Est #tradeideas

0 · Reply

DARKP00L May. 6 at 12:46 PM

$MASS 07:15 on May. 06 2026 908 Devices To Acquire NIRLAB AG, A Maker Of AI-Powered, Cloud-Connected Near-Infrared Spectroscopy To Perform Handheld Chemical Analysis Of Narcotics, Terms Not Disclosed #tradeideas

0 · Reply

focafoca99 May. 6 at 12:34 PM

$MASS acquired NIRLAB SA in a $15 million deal, paying cash and issuing stock.

0 · Reply

StocktwitsEarnings May. 6 at 11:39 AM

$MASS Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.32 down -126.02% YoY • Reported revenue of $13.38M up 13.62% YoY • 908 Devices now expects full year 2026 revenues to be in the range of $67M to $70M, representing 19% to 25% growth compared to 2025 revenue.

0 · Reply

lorenaw May. 6 at 10:16 AM

$MASS 🤔

0 · Reply

BillionerOfKing May. 4 at 6:44 PM

$MASS Current Stock Price: $6.63 Contracts to trade: $7.5 MASS May 15 2026 Call Entry: $0.10 Exit: $0.20 ROI: 99% Hold ~27 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

SuperGreenToday Apr. 30 at 10:07 PM

$MASS Share Price: $6.82 Contract Selected: Nov 20, 2026 $5 Calls Buy Zone: $1.70 – $2.10 Target Zone: $2.99 – $3.66 Potential Upside: 66% ROI Time to Expiration: 203 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

908 Devices Earnings Call Transcript: Q1 2026

May 6, 2026, 7:30 AM EDT - 14 hours ago

908 Devices Reports First Quarter 2026 Financial Results and Raises 2026 Revenue Outlook

May 6, 2026, 7:00 AM EDT - 15 hours ago

908 Devices Acquires NIRLAB AG, Expanding Its Narcotics Detection Portfolio

May 1, 2026, 8:30 AM EDT - 5 days ago

908 Devices to Report First Quarter 2026 Financial Results on May 6, 2026

Apr 21, 2026, 5:00 PM EDT - 15 days ago

908 Devices Appoints Kola Otitoju as Chief Business & Strategy Officer and Announces an Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Mar 18, 2026, 1:45 PM EDT - 7 weeks ago

908 Devices Transcript: Sidoti March Small-Cap Virtual Conference

Mar 16, 2026, 7:00 AM EDT - 7 weeks ago

908 Devices to Present at the Sidoti Small Cap Conference

Mar 9, 2026, 1:40 PM EDT - 2 months ago

908 Devices Transcript: Leerink Global Healthcare Conference 2026

Mar 4, 2026, 9:10 AM EST - 2 months ago

908 Devices Transcript: TD Cowen 46th Annual Health Care Conference

Mar 3, 2026, 8:30 AM EST - 2 months ago

908 Devices Earnings Call Transcript: Q4 2025

Mar 3, 2026, 7:00 AM EST - 2 months ago

908 Devices Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Revenue Outlook

Feb 24, 2026, 7:00 AM EST - 2 months ago

908 Devices to Participate in Investor Conferences in March

Feb 17, 2026, 7:00 AM EST - 2 months ago

908 Devices to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026

Feb 5, 2026, 7:00 AM EST - 3 months ago

908 Devices Enhances MX908 Usability and Adds New Drug Targets

Jan 20, 2026, 7:00 AM EST - 3 months ago

908 Devices Announces Strong Preliminary Financial Results for Fourth Quarter and Full Year 2025

Nov 20, 2025, 11:00 AM EST - 5 months ago

908 Devices Transcript: Stephens Annual Investment Conference

Nov 12, 2025, 8:40 AM EST - 6 months ago

908 Devices Transcript: Stifel 2025 Healthcare Conference

Nov 10, 2025, 8:30 AM EST - 6 months ago

908 Devices Earnings Call Transcript: Q3 2025

Nov 10, 2025, 7:00 AM EST - 6 months ago

908 Devices Reports Third Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook

Oct 30, 2025, 7:00 AM EDT - 6 months ago

908 Devices to Participate in Upcoming Investor Conferences

Oct 28, 2025, 7:00 AM EDT - 6 months ago

United States Coast Guard Purchases 908 Devices' Handheld Mass Spec Devices for Chemical Threat Identification

Oct 22, 2025, 7:00 AM EDT - 7 months ago

908 Devices to Report Third Quarter 2025 Financial Results on November 10, 2025

Oct 16, 2025, 7:00 AM EDT - 7 months ago

United States Marine Corps Purchases 908 Devices' XplorIR Gas Identification Devices

Aug 13, 2025, 1:00 PM EDT - 9 months ago

908 Devices Transcript: Canaccord Genuity’s 45th Annual Growth Conference

Aug 5, 2025, 8:30 AM EDT - 9 months ago

908 Devices Earnings Call Transcript: Q2 2025

Aug 5, 2025, 7:00 AM EDT - 9 months ago

908 Devices Reports Second Quarter 2025 Financial Results and Raises 2025 Revenue Outlook

Aug 4, 2025, 7:00 AM EDT - 9 months ago

908 Devices Appoints Dr. Brandi Vann, former U.S. Principal Deputy Assistant Secretary for Nuclear, Chemical, and Biological Defense, to its Board of Directors

Jul 29, 2025, 7:00 AM EDT - 10 months ago

908 Devices to Participate in the Canaccord Genuity 45th Annual Growth Conference

Jul 22, 2025, 7:00 AM EDT - 10 months ago

908 Devices to Report Second Quarter 2025 Financial Results on August 5, 2025

Jul 8, 2025, 7:00 AM EDT - 10 months ago

908 Devices Launches VipIR, a 3-in-1 Handheld Analyzer for Field-Based Chemical Identification of Unknown Bulk Substances

Jun 25, 2025, 8:03 AM EDT - 11 months ago

Asylon Robotics and 908 Devices Deliver Robotic Security at the 2025 Indianapolis 500

Jun 16, 2025, 8:00 AM EDT - 11 months ago

908 Devices Appoints Christopher D. Brown to its Board of Directors

RGEN

Jun 4, 2025, 5:00 PM EDT - 1 year ago

908 Devices Transcript: 45th Annual William Blair Growth Stock Conference

Jun 3, 2025, 7:00 AM EDT - 1 year ago

Metropolitan Washington Council of Governments Adds 908 Devices' XplorIR to Its Hazardous Materials Response Toolkit

May 22, 2025, 7:00 AM EDT - 1 year ago

908 Devices to Participate in the William Blair 45th Annual Growth Stock Conference

May 13, 2025, 8:30 AM EDT - 1 year ago

908 Devices Earnings Call Transcript: Q1 2025

May 13, 2025, 7:00 AM EDT - 1 year ago

908 Devices Reports First Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook

Apr 30, 2025, 7:00 AM EDT - 1 year ago

908 Devices Equips rescEU Disaster Preparedness Reserve with Advanced Chemical Detection

Apr 22, 2025, 7:00 AM EDT - 1 year ago

908 Devices Receives $2M Order from the Texas Department of Public Safety for Drug Detection and Mitigation

Mar 11, 2025, 1:00 PM EDT - 1 year ago

908 Devices Transcript: Leerink’s Global Healthcare Conference 2025

Mar 11, 2025, 7:00 AM EDT - 1 year ago

908 Devices Receives $1.7M Order from the Ministry of Health of Ukraine for its Handheld Mass Spec Device

Mar 5, 2025, 9:50 AM EST - 1 year ago

908 Devices Transcript: TD Cowen 45th Annual Healthcare Conference

Mar 4, 2025, 1:26 PM EST - 1 year ago

908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth

RGEN

Mar 4, 2025, 8:30 AM EST - 1 year ago

908 Devices Earnings Call Transcript: Q4 2024

Mar 4, 2025, 7:45 AM EST - 1 year ago

908 Devices Announces Strategic Transformation and Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 4, 2025, 7:30 AM EST - 1 year ago

Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices

RGEN

Mar 3, 2025, 4:30 PM EST - 1 year ago

908 Devices to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025

Jan 14, 2025, 4:01 PM EST - 1 year ago

908 Devices Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results

Dec 19, 2024, 7:00 AM EST - 1 year ago

Getinge and 908 Devices Partner to Enhance Bioreactor Capabilities for Continuous Monitoring of Key Cell Culture Parameters

Nov 19, 2024, 8:35 AM EST - 1 year ago

908 Devices Transcript: Stifel 2024 Healthcare Conference

Nov 12, 2024, 8:30 AM EST - 1 year ago

908 Devices Earnings Call Transcript: Q3 2024

Nov 12, 2024, 7:00 AM EST - 1 year ago

908 Devices Reports Third Quarter 2024 Financial Results and Updates 2024 Revenue Outlook

Oct 22, 2024, 7:00 AM EDT - 1 year ago

908 Devices to Report Third Quarter 2024 Financial Results on November 12, 2024

Sep 6, 2024, 7:00 AM EDT - 1 year ago

908 Devices to Participate in Craig-Hallum Bioprocessing Conference

Aug 13, 2024, 1:00 PM EDT - 1 year ago

908 Devices Transcript: Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024

Aug 6, 2024, 8:30 AM EDT - 1 year ago

908 Devices Earnings Call Transcript: Q2 2024

Aug 6, 2024, 7:00 AM EDT - 1 year ago

908 Devices Reports Second Quarter 2024 Financial Results and Reiterates 2024 Revenue Outlook

Aug 6, 2024, 7:00 AM EDT - 1 year ago

25 Snack Food Suppliers Queue Up for ReposiTrak's Rapidly Expanding Food Traceability Network

BCYC BSY MLI NJR OFIX QBTS SMMT

Jul 30, 2024, 7:00 AM EDT - 1 year ago

908 Devices to Participate in Canaccord Genuity 44th Annual Growth Conference

Jul 23, 2024, 7:00 AM EDT - 1 year ago

908 Devices to Report Second Quarter 2024 Financial Results on August 6, 2024

Jun 25, 2024, 7:00 AM EDT - 2 years ago

908 Devices Appoints Michele M. Leonhart, Former Administrator of the United States Drug Enforcement Administration (DEA), to Its Board of Directors

Jun 18, 2024, 7:00 AM EDT - 2 years ago

908 Devices Enhances XplorIR Portable Analyzer to Simultaneously Identify and Quantify Hazardous Gases and Vapors

Jun 4, 2024, 11:40 AM EDT - 2 years ago

908 Devices Transcript: The 44th Annual William Blair Growth Stock Conference

May 29, 2024, 9:00 AM EDT - 2 years ago

908 Devices Transcript: 2024 Leerink Partners Healthcare Crossroads Conference

Apr 30, 2024, 8:30 AM EDT - 2 years ago

908 Devices Earnings Call Transcript: Q1 2024

Apr 30, 2024, 7:45 AM EDT - 2 years ago

908 Devices Reports First Quarter 2024 Financial Results and Updates 2024 Revenue Outlook

Apr 30, 2024, 7:30 AM EDT - 2 years ago

908 Devices Acquires RedWave Technology, Expanding its Forensics Product Offering

Apr 23, 2024, 7:00 AM EDT - 2 years ago

908 Devices to Report First Quarter 2024 Financial Results on April 30, 2024

Mar 20, 2024, 3:45 PM EDT - 2 years ago

908 Devices Transcript: KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

Mar 12, 2024, 7:00 AM EDT - 2 years ago

908 Devices Trace Chemical Identification Technology Adopted by European Agencies

Mar 5, 2024, 8:30 AM EST - 2 years ago

908 Devices Earnings Call Transcript: Q4 2023

Mar 5, 2024, 7:00 AM EST - 2 years ago

908 Devices Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Revenue Outlook

Feb 29, 2024, 7:00 AM EST - 2 years ago

908 Devices and Cellares Collaborate to Integrate In-line Monitoring of Bioprocess Parameters into the Cell Shuttle, Cellares' Fully Integrated Cell Therapy Manufacturing Platform

Feb 20, 2024, 7:00 AM EST - 2 years ago

908 Devices to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024

LandonCapital May. 6 at 4:59 PM

$MASS https://landoncapital.net/908-devices-acquires-nirlab-for-15-million-in-narcotics-detection-deal/

0 · Reply

xbizo May. 6 at 2:20 PM

$MASS Guidance raise VipIR rollout confirmation Smiths Spring Award coming Neurolab acquisition 30% recurring revenue milestone hit Near-zero cash burn

1 · Reply

xbizo May. 6 at 2:09 PM

$MASS run to $10 and back off from there? Thoughts?

0 · Reply

DARKP00L May. 6 at 12:47 PM

$MASS 07:38 on May. 06 2026 908 Devices Raises FY2026 Sales Guidance from $64.500M-$67.500M to $67.000M-$70.000M vs $65.808M Est #tradeideas

0 · Reply

DARKP00L May. 6 at 12:46 PM

0 · Reply

focafoca99 May. 6 at 12:34 PM

$MASS acquired NIRLAB SA in a $15 million deal, paying cash and issuing stock.

0 · Reply

StocktwitsEarnings May. 6 at 11:39 AM

0 · Reply

lorenaw May. 6 at 10:16 AM

$MASS 🤔

0 · Reply

BillionerOfKing May. 4 at 6:44 PM

0 · Reply

SuperGreenToday Apr. 30 at 10:07 PM

0 · Reply

Tahabder Apr. 27 at 10:49 PM

$MASS

0 · Reply

xbizo Apr. 9 at 4:34 PM

$MASS Visibility on this one is tough. $70MM revenue this year. Growth is solid, but not exciting for such low level of revenue. Maybe it doubles and reaches breakeven EBITDA by 2029? Any insights on catalysts?

0 · Reply

PatrickandFrankie Apr. 9 at 11:52 AM

$MASS 908 Devices 908 Devices According to AI: Why It Might Seem Like Sales are Limited Devices leadership recently noted they are waiting for impacts from the $150 billion appropriated for DHS and Border Patrol in the 2026 fiscal year. Replacement Cycles: Many agencies still use older technologies Strategic Pivot: The company only recently (early 2025) sold its bioprocessing business to focus 100% on the handheld defense and public safety market, which includes aggressive expansion into more DHS departments.

0 · Reply

OfficialStocktwitsUser Mar. 27 at 6:56 PM

$MASS RSI: 32.83, MACD: -0.1122 Vol: 0.24, MA20: 6.24, MA50: 6.43 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Sidoti Mar. 20 at 10:35 PM

908 Devices ($MASS) Management Team presented at the Sidoti Small-Cap Virtual Conference this week. Watch the replay here: https://sidoti.zoom.us/webinar/register/WN_rb94-xr9QPyFewc5E6MmJQ

0 · Reply

Helloa11 Mar. 3 at 2:23 PM

$MASS How how can this go today ?

0 · Reply

JasonCO Mar. 3 at 12:29 PM

$MASS ARKK average is in the $40’s

1 · Reply

StocktwitsEarnings Mar. 3 at 12:22 PM

$MASS Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.11 up 119.64% YoY • Reported revenue of $17.38M down -7.65% YoY • 908 Devices expects full year 2026 revenues to be in the range of $64.5M to $67.5M, representing 15% to 20% growth compared to 2025 revenue from continuing operations.

0 · Reply

ElizabethVoorhees140 Feb. 21 at 6:48 AM

$MASS Massimo Group operates specialty manufacturing. Revenue visibility is limited. Liquidity risk remains high.

0 · Reply

OfficialStocktwitsUser Feb. 13 at 5:14 PM

$MASS RSI: 50.36, MACD: 0.1718 Vol: 0.34, MA20: 6.51, MA50: 6.05 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

lorenaw Feb. 8 at 11:24 PM

$MASS let’s go 🏈🏈🏈 !!! Good luck New England 🔥🔥🔥Patriots Superbowl LX 👏🏼👏🏼👏🏼👏🏼👏🏼👏🏼

1 · Reply

DARKP00L Feb. 5 at 12:17 PM

$MASS 07:17 on Feb. 05 2026 908 Devices Updates MX908 Mission Mode For Hazardous Vapor Sampling And Adds Five New Drug Targets Including Medetomidine #tradeideas

0 · Reply

Market Cap	265.50M
Revenue (ttm)	56.20M
Net Income (ttm)	19.49M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	34.68%
Debt to Equity Ratio	0.00

Volume	630,400
Avg Vol	274,568
Day's Range	N/A - N/A
Shares Out	37.45M
Stochastic %K	92%
Beta	0.57
Analysts	Strong Sell
Price Target	$10.00